Acoramidis is a small-molecule transthyretin stabilizer designed to treat cardiomyopathy and polyneuropathy associated with transthyretin amyloidosis. This category provides essential reference standards,… Read more













Acoramidis is a small-molecule transthyretin stabilizer designed to treat cardiomyopathy and polyneuropathy associated with transthyretin amyloidosis. This category provides essential reference standards, including the active pharmaceutical ingredient, to support rigorous analytical testing and quality control processes. Laboratories utilize these high-quality compounds for impurity profiling and method validation, ensuring accurate characterization of the drug substance. The collection encompasses critical related substances such as bromopropoxy and acetone acetyl impurities, which must be monitored during manufacturing and stability studies. Furthermore, the range includes significant metabolites, such as acyl beta-D-glucuronide, and stable isotope-labelled compounds. These labelled standards serve as vital internal standards in mass spectrometry, allowing for precise quantification and pharmacokinetic analysis. By providing these specialized materials, this catalogue facilitates comprehensive research and regulatory compliance throughout the pharmaceutical development lifecycle.